December 11, 2007 - ValveXchange, developer of a next-generation replacement heart valve technology, won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 Conference & Expo in Denver.
The Venture Showcase Award was provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards Luncheon.
ValveXchange holds patented technology on a two-piece bioprosthetic tissue valve that reportedly resolves the compromises between conventional mechanical and tissue heart valves. ValveXchange has exclusively licensed its core technology, invented by founder Ivan Vesely, PhD, from The Cleveland Clinic Foundation. Funding from the founder and three SBIR grants has allowed for prototypes developed with proof of concept, two-piece exchangeable tissue valve, functional & mechanical tests, in vitro testing of prototypes, validated performance and in vivo testing. The company says it is initiating recruitment of Angel and Series A Financing of $2.5 million to bring the technology to the clinical trial stage.
For more information: www.valvexchange.com
April 17, 2024 
